BioCentury
ARTICLE | Company News

Mesoblast, Cambrex deal

September 26, 2005 7:00 AM UTC

CBM will produce clinical-grade batches of MSB's adult stem cells. MSB is developing the stem cell technology to treat orthopedic conditions, including the regeneration and repair of bone and cartilag...